ROYAL BANK OF CANADA - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 97 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2018. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2023$0
-100.0%
43
-98.2%
0.00%
Q2 2023$4,000
+300.0%
2,402
+40.3%
0.00%
Q1 2023$1,0000.0%1,712
+21.5%
0.00%
Q4 2022$1,000
-50.0%
1,409
-43.9%
0.00%
Q3 2022$2,0002,511
+757.0%
0.00%
Q2 2022$0
-100.0%
293
-94.5%
0.00%
Q1 2022$7,000
-74.1%
5,338
-65.8%
0.00%
Q4 2021$27,000
+50.0%
15,607
+88.6%
0.00%
Q3 2021$18,000
-28.0%
8,275
+15.0%
0.00%
Q2 2021$25,000
-75.0%
7,197
-29.2%
0.00%
Q1 2021$100,000
+300.0%
10,163
+349.9%
0.00%
Q4 2020$25,000
+150.0%
2,259
+125.9%
0.00%
Q3 2020$10,000
-90.8%
1,000
-80.8%
0.00%
Q2 2020$109,000
+738.5%
5,208
+296.6%
0.00%
Q1 2020$13,000
-51.9%
1,313
-43.7%
0.00%
Q4 2019$27,000
+350.0%
2,333
+147.4%
0.00%
Q3 2018$6,000
-70.0%
943
-83.3%
0.00%
Q4 2017$20,000
-4.8%
5,654
-0.4%
0.00%
Q3 2017$21,000
+50.0%
5,674
+0.4%
0.00%
Q2 2017$14,000
-17.6%
5,654
-13.2%
0.00%
Q1 2017$17,000
-5.6%
6,515
+3.6%
0.00%
Q4 2016$18,000
-21.7%
6,288
+11.2%
0.00%
Q3 2016$23,000
+27.8%
5,6540.0%0.00%
Q2 2016$18,0005,6540.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q1 2018
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,112,355$40,178,00034.81%
Versant Venture Management, LLC 7,068,233$69,056,636,00018.94%
ACUTA CAPITAL PARTNERS, LLC 1,704,500$16,653,0008.07%
Soleus Capital Management, L.P. 313,900$3,067,0003.57%
Ghost Tree Capital, LLC 1,305,500$12,755,0003.38%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$4,690,0002.97%
RTW INVESTMENTS, LP 6,631,627$64,791,0002.79%
VR Adviser, LLC 994,381$9,715,0002.63%
Avoro Capital Advisors LLC 7,150,000$69,856,0002.36%
RA Capital Management 7,272,714$71,054,0002.24%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders